tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
JPMorgan views Medicare price cuts as inline with expectations
PremiumThe FlyJPMorgan views Medicare price cuts as inline with expectations
12d ago
AbbVie announces FDA approval of Epkinly in combo with rituximab, lenalidomide
Premium
The Fly
AbbVie announces FDA approval of Epkinly in combo with rituximab, lenalidomide
20d ago
AbbVie says new Lupron Depot strength receives Health Canada Approval
Premium
The Fly
AbbVie says new Lupron Depot strength receives Health Canada Approval
21d ago
AbbVie initiated with an Outperform at Scotiabank
PremiumThe FlyAbbVie initiated with an Outperform at Scotiabank
26d ago
AbbVie ending partnership with Calico Life Sciences, STAT reports
Premium
The Fly
AbbVie ending partnership with Calico Life Sciences, STAT reports
26d ago
GH Research price target lowered to $35 from $40 at H.C. Wainwright
Premium
The Fly
GH Research price target lowered to $35 from $40 at H.C. Wainwright
28d ago
AbbVie price target lowered to $248 from $251 at BofA
PremiumThe FlyAbbVie price target lowered to $248 from $251 at BofA
1M ago
AbbVie price target raised to $260 from $250 at JPMorgan
Premium
The Fly
AbbVie price target raised to $260 from $250 at JPMorgan
1M ago
AbbVie price target lowered to $235 from $240 at Citi
Premium
The Fly
AbbVie price target lowered to $235 from $240 at Citi
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100